Determining the role of dynamic hyperinflation in patients with severe chronic obstructive pulmonary disease

Respiration

Volumn 90, Issue 4, 2015, Pages 306-313

  Klooster, Karin ^a   Ten Hacken, Nick H T ^a   Hartman, Jorine E ^a   Sciurba, Frank C ^b   Kerstjens, Huib A M ^a   Slebos, Dirk Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Dynamic hyperinflation; Exercise capacity; Inspiratory capacity; Static hyperinflation

Indexed keywords

CARBON MONOXIDE; SALBUTAMOL;

ADD ON THERAPY; ADULT; AIRWAY RESISTANCE; ARTICLE; BODY PLETHYSMOGRAPHY; BREATHING RATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE SEVERITY; DYNAMIC HYPERINFLATION; END TIDAL CARBON DIOXIDE TENSION; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; LUNG CAPACITY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RESIDUAL VOLUME; REST; SITTING; SPIROMETRY; TACHYPNEA; TIDAL VOLUME; TOTAL LUNG CAPACITY; VITAL CAPACITY; WALKING; AGED; CLINICAL TRIAL; EXERCISE TEST; EXERCISE TOLERANCE; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

AGED; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84946498398     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000439056     Document Type: Article

References (30)

1. ODonnell DE, Laveneziana P. Dyspnea and activity limitation in COPD: mechanical factors. COPD 2007; 4: 225-236
2. Gelb AF, Gutierrez CA, Weisman IM, Newsom R, Taylor CF, Zamel N. Simplified detection of dynamic hyperinflation. Chest 2004; 126: 1855-1860
3. Cooper CB. Airflow obstruction and exercise. Respir Med 2009; 103: 325-334
4. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006; 119: 21-31
5. Hyatt RE. The interrelationships of pressure, flow, and volume during various respiratory maneuvers in normal and emphysematous subjects. Am Rev Respir Dis 1961; 83: 676-683
6. Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 1967; 22: 95-108
7. Eltayara L, Becklake MR, Volta CA, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 1726-1734
8. Casanova C, Cote C, De Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-597
9. Tantucci C. Expiratory flow limitation definition, mechanisms, methods, and significance. Pulm Med 2013; 2013: 749860
10. Stubbing DG, Pengelly LD, Morse JL, Jones NL. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol Respir Environ Exerc Physiol 1980; 49: 511-515
11. Oonnell DE. Ventilatory limitations in chronic obstructive pulmonary disease. Med Sci Sports Exerc 2001; 33: S647-S655
12. ODonnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993; 148: 1351-1357
13. Calligaro GL, Raine RI, Bateman ME, Bateman ED, Cooper CB. Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exercise. COPD 2014; 11: 105-112
14. Weigt SS, Abrazado M, Kleerup EC, Tashkin DP, Cooper CB. Time course and degree of hyperinflation with metronome-paced tachypnea in COPD patients. COPD 2008; 5: 298-304
15. Fujimoto K, Yoshiike F, Yasuo M, Kitaguchi Y, Urushihata K, Kubo K, Honda T. Effects of bronchodilators on dynamic hyperinflation following hyperventilation in patients with cOPD. Respirology 2007; 12: 93-99
16. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van Der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force: General considerations for lung function testing. Eur Respir J 2005; 26: 153-161
17. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van Der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 2005; 26: 319-338
18. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. Eur Respir J 1995; 8: 492-506
19. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117
20. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. Georges Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327
21. Jones PW. St. George Respiratory Questionnaire: MCID. COPD 2005; 2: 75-79
22. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586
23. Yan S, Kaminski D, Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 55-59
24. Cooper CB, Calligaro GL, Quinn MM, Eshaghian P, Coskun F, Abrazado M, Bateman ED, Raine RI. Determinants of dynamic hyperinflation during metronome-paced tachypnea in COPD and normal subjects. Respir Physiol Neurobiol 2014; 190: 76-80
25. Hannink J, Lahaije A, Bischoff E, van Helvoort H, Dekhuijzen R, Schermer T, Heijdra Y. Dynamic hyperinflation after metronomepaced hyperventilation in COPD - A 2 year follow-up. Respir Med 2010; 104: 1700-1705
26. Lahaije A, van Helvoort H, Dekhuijzen R, Heijdra Y. Can COPD patients who hyperinflate during daily life activities be identified by laboratory tests?. Respiration 2013; 86: 237-242
27. Johnson BD, Reddan WG, Pegelow DF, Seow KC, Dempsey JA. Flow limitation and regulation of functional residual capacity during exercise in a physically active aging population. Am Rev Respir Dis 1991; 143: 960-967
28. Guenette JA, Webb KA, ODonnell DE. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with cOPD?. Eur Respir J 2012; 40: 322-329
29. Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-Collazo E, Alvarez-Sala R. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009; 180: 506-512
30. Lahaije AJ, Willems LM, van Hees HW, Dekhuijzen PN, van Helvoort HA, Heijdra YF. Diagnostic accuracy of metronomepaced tachypnea to detect dynamic hyperinflation. Clin Physiol Funct Imaging 2013; 33: 62-69